UNSPSC 51162014: Butabarbital/epinephrine/theophylline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162014 Butabarbital/epinephrine/theophylline, a Commodity-tier code, does not reflect the pharmaceutical procurement activity currently being solicited by state and local governments. The four recent opportunities posted under this code involve naloxone and drug deactivation systems, on-site pharmacy services, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which map to the specific drug combination named in the code. The mismatch suggests either a classification error in how issuing bodies are tagging their solicitations or that this code has shifted in application. The actual purchasing pattern across these opportunities covers pharmaceutical supply, wholesale drug distribution, pharmacy benefit management, and emergency medical supplies, reflecting operational healthcare and emergency-response procurement rather than a single therapeutic compound.

The issuing bodies span state health authorities, county governments, and cooperative purchasing consortia. The Texas Health and Human Services Commission posted an RFI exploring direct-to-manufacturer prescription relationships (Apr 3, 2026). Seminole County, Florida released an IFB for naloxone and drug deactivation systems with a due date of Jul 26, 2023 (IFB60459723LAS). Hall County, Georgia issued an RFQ/P for on-site pharmacy services with a response deadline of Jun 4, 2026 (PE77129NONST2027000000066). The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP for generic multi-source pharmaceuticals and OTC products due Mar 26, 2026 (S1070000015802), serving participating state and local government facilities including Oregon. Activity concentrates in the Southeast and Upper Midwest, with the MMCAP cooperative offering multi-state reach. Given the code's apparent misalignment with actual solicitation content, this code shows little relevant recent activity for vendors specializing in the butabarbital/epinephrine/theophylline formulation.